Literature DB >> 1708850

Pancreatoblastoma: response to chemotherapy.

J P Vannier1, F Flamant, J Hemet, J M Caillaud, M Gruner, B Bachy, R Lefur, J Lemerle, P Tron.   

Abstract

Two cases of pancreatoblastoma in children are reported here. Only biopsies were made at laparotomy as surgical resection by duodeno-pancreatectomy was not possible. In both children a dramatic response was observed with chemotherapy: doxorubicin plus cisplatin for one, cyclophosphamide, actinomycin D, bleomycin, vinblastine sulfate, and cisplatin for the other. After completion of the chemotherapy the first patient had a local resection; then he had radiotherapy. He is alive in first remission 40 months after the end of the treatment. In the second patient, regional recurrence occurred 8 months after chemotherapy was ended. A transient second remission was obtained with ifosfamide plus etoposide alternating with epirubicin plus vincristine. The patient died 36 months after the diagnosis. Therefore, these two cases suggest that chemotherapy may be proposed before any attempt at surgical excision. Nevertheless, early consolidation by radical resection or irradiation must be considered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708850     DOI: 10.1002/mpo.2950190308

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

1.  Pancreatic tumors in children.

Authors:  J Grochowski; T Malek; W Miezyński; P K Wojciechowski
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

2.  Diagnosis and treatment of pancreatoblastoma in children: a retrospective study in a single pediatric center.

Authors:  YiJin Huang; Wei Yang; JiaJian Hu; ZhiYun Zhu; Hong Qin; Wei Han; HuanMin Wang
Journal:  Pediatr Surg Int       Date:  2019-07-23       Impact factor: 1.827

3.  CT, MRI, and color Doppler ultrasound correlation of pancreatoblastoma: a case report.

Authors:  B Lumkin; M W Anderson; D S Ablin; J P McGahan
Journal:  Pediatr Radiol       Date:  1993
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.